Full Text View
Tabular View
No Study Results Posted
Related Studies
Database Surveillance Safety Study of PENTACEL® Vaccine
This study is ongoing, but not recruiting participants.
Study NCT00804284   Information provided by Sanofi

First Received on December 5, 2008.   Last Updated on April 24, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diphtheria
Tetanus
Pertussis
Haemophilus Influenzae
Additional conditions recognized in this trial
Haemophilus Infections
Influenza, Human
Tetany
Whooping Cough
More general conditions related to this trial
Actinomycetales Infections
Bacterial Infections
Bordetella Infections
Calcium Metabolism Disorders
Clostridium Infections
Corynebacterium Infections
Gram-Negative Bacterial Infections
Gram-Positive Bacterial Infections
Hypocalcemia
Infection
Metabolic Diseases
Nervous System Diseases
Neurologic Manifestations
Neuromuscular Manifestations
Orthomyxoviridae Infections
Pasteurellaceae Infections
Respiratory Tract Diseases
Respiratory Tract Infections
RNA Virus Infections
Signs and Symptoms
Virus Diseases
Interventions listed in this trial
DTaP-IPV/Hib
Other DTap Vaccines
Sponsors listed in this trial
Sanofi Pasteur, a Sanofi Company


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services